Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Bladder-Renal Cancer | Suspected | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Botulinum toxin type A | Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Budesonide targeted release (Kinpeygo) | Primary IgA nephropathy | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Calcium acetate | Hyperphosphatemia in adult patients with chronic kidney disease | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Canagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Catheter formulary | Continence | n/a | Prescribing guideline | East and North Hertfordshire, South and West Hertfordshire |
| Catheter formulary | Continence | n/a | Prescribing guideline | West Essex |
| Catheter Prescription Ordering Form | Continence | n/a | Primary Care prescribing resource | East and North Hertfordshire, South and West Hertfordshire |
| Cervical Screening Decision for Adults with Learning Difficulties | n/a | Clinical pathways | South and West Hertfordshire | |
| Chronic Kidney Disease - Treatment Pathway | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Cystistat | Chronic inflammation or infection of the bladder | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Dapagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Dapagliflozin Switch Guidance | n/a | Prescribing guideline | Hertfordshire and West Essex ICB | |
| Doxazosin (prolonged release) | Hypertension, benign prostatic hyperplasia (BPH) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Doxazosin Prolonged-Release Patient Information Leaflet | Hypertension, benign prostatic hyperplasia (BPH) | n/a | Patient information | Hertfordshire and West Essex ICB |
| Empagliflozin | Chronic kidney disease | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Erectile dysfunction guidelines | Erectile dysfunction | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Finerenone | Chronic kidney disease | Green | Prescribing support document | Hertfordshire and West Essex ICB |
| Haematospermia | n/a | Clinical pathways | South and West Hertfordshire | |
| Haematuria | n/a | Clinical pathways | South and West Hertfordshire | |
| iAluRil | Chronic inflammation or infection of the bladder | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Loin Pain Renal Colic | n/a | n/a | South and West Hertfordshire | |
| Mirabegron | neurogenic detrusor overactivity in people 3 to 17 years | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nephrotrans® (sodium hydrogen carbonate gastro-resistant 500mg capsules) | Metabolic acidosis in adults with chronic kidney disease | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Oxybutynin oral solution to Tablets switch Patient Letter | urinary incontinence | n/a | Patient information | Hertfordshire and West Essex ICB |
| Patiromer | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Pelvic Mass/Cancer | UI Physical Assessment | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Penile Circumcision | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Pentosan polysulfate sodium | Bladder pain syndrome | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peyronie’s Disease | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Potassium binders | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Reversal of Sterilisation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Roxadustat | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Sodium zirconium | Hyperkalaemia of CKD | Amber initiation | Prescribing pathway | Hertfordshire and West Essex ICB |
| Sparsentan | Primary IgA nephropathy | Red | Decision document | Hertfordshire and West Essex ICB |
| Tadalafil | Penile rehabilitation | Red | n/a | Hertfordshire and West Essex ICB |
| Tadalafil | Benign prostatic hyperplasia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Urinary incontinence | Adults | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Incontinence (UI) | n/a | Clinical pathways | East and North Hertfordshire | |
| Urinary Incontinence (UI) Initial Assessment of Women: dipstick urine testing pathway | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Urinary Tract Infections (UTIs) | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
| Vasectomy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Vasectomy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
| Vibegron | Overactive bladder syndrome | Green | NICE technology appraisal | Hertfordshire and West Essex ICB |